Test Bank Complete_ Stahl's Essential Psychopharmacology Neuroscientific Basis and Practical Applications 5th Edition, Stephen M. Stahl (Author) All Chapters 1-13

TEST BANK FOR STAHL'S ESSENTIAL PSYCHOPHARMACOLOGY 5TH EDITION
NEUROSCIENTIFIC BASIS AND PRACTICAL APPLICATIONS BY STEPHEN M. STAHL
9781108838573 CHAPTER 1-14 COMPLETE GUIDE.

,Table of Contents
CHAPTER 1 CHEMICAL NEUROTRANSMISSION......................................................................................... 3
CHAPTER 2 TRANSPORTERS, RECEPTORS, AND ENZYMES AS TARGETS OF PSYCHOPHARMACOLOGICAL
DRUG ACTION ......................................................................................................................................... 15
CHAPTER 3 ION CHANNELS AS TARGETS OF PSYCHOPHARMACOLOGICAL DRUG ACTION ................... 23
CHAPTER 4 PSYCHOSIS AND SCHIZOPHRENIA ........................................................................................ 32
CHAPTER 5 ANTIPSYCHOTIC AGENTS...................................................................................................... 57
CHAPTER 6 MOOD DISORDERS ............................................................................................................... 67
CHAPTER 7 ANTIDEPRESSANTS ............................................................................................................... 80
CHAPTER 8 MOOD STABILIZERS .............................................................................................................. 93
CHAPTER 9 ANXIETY DISORDERS AND ANXIOLYTICS ............................................................................ 117
CHAPTER 10 CHRONIC PAIN AND ITS TREATMENT............................................................................... 128
CHAPTER 11 DISORDERS OF SLEEP AND WAKEFULNESS AND THEIR TREATMENT .............................. 140
CHAPTER 12 ATTENTION DEFICIT HYPERACTIVITY DISORDER AND ITS TREATMENT ........................... 149
CHAPTER 13 DEMENTIA AND ITS TREATMENT ..................................................................................... 163
CHAPTER 14 IMPULSIVITY, COMPULSIVITY, AND ADDICTION .............................................................. 184

,CHAPTER 1 CHEMICAL NEUROTRANSMISSION
MULTIPLE CHOICE
1. A PATIENT WITH DEPRESSION MENTIONS TO THE NURSE, MY MOTHER SAYS
DEPRESSION IS A CHEMICAL DISORDER. WHAT DOES SHE MEAN? THE NURSES RESPONSE IS
BASED ON THE THEORY
THAT DEPRESSION PRIMARILY INVOLVES WHICH OF THE FOLLOWING NEUROTRANSMITTERS?
A. CORTISOL AND GABA
B. COMT AND GLUTAMATE


C. MONAMINE AND GLYCINE


D. SEROTONIN AND NOREPINEPHRINE
ANSWER: D
ONE POSSIBLE CAUSE OF DEPRESSION IS THOUGHT TO INVOLVE ONE OR MORE
NEUROTRANSMITTERS.
SEROTONIN AND NOREPINEPHRINE HAVE BEEN FOUND TO BE IMPORTANT IN THE REGULATION
OF DEPRESSION. THERE IS NO RESEARCH TO SUPPORT THAT THE OTHER OPTIONS PLAY A
SIGNIFICANT ROLE IN THE DEVELOPMENT OF DEPRESSION.
2. A PATIENT HAS EXPERIENCED A STROKE (CEREBRAL VASCULAR ACCIDENT) THAT HAS
RESULTED IN DAMAGE TO THE BROCA AREA. WHICH EVALUATION DOES THE NURSE CONDUCT
TO REINFORCE THIS DIAGNOSIS?
A. OBSERVING THE PATIENT PICK UP A SPOON
B. ASKING THE PATIENT TO RECITE THE ALPHABET


C. MONITORING THE PATIENTS BLOOD PRESSURE


D. COMPARING THE PATIENTS GRIP STRENGTH IN BOTH HANDS
ANSWER: B
ACCIDENTS OR STROKES THAT DAMAGE BROCAS AREA MAY RESULT IN THE INABILITY TO SPEAK
(I.E.,

, MOTOR APHASIA). FINE MOTOR SKILLS, BLOOD PRESSURE CONTROL, AND MUSCLE STRENGTH
ARE NOT CONTROLLED BY THE BROCA AREA OF THE LEFT FRONTAL LOBE.
3. THE PATIENT DIAGNOSED WITH SCHIZOPHRENIA ASKS WHY PSYCHOTROPIC
MEDICATIONS ARE ALWAYS PRESCRIBED BY THE DOCTOR. THE NURSES ANSWER WILL BE
BASED ON INFORMATION THAT
THE THERAPEUTIC ACTION OF PSYCHOTROPIC DRUGS IS THE RESULT OF THEIR EFFECT ON:
A. THE TEMPORAL LOBE; ESPECIALLY WERNICKES AREA
B. DENDRITES AND THEIR ABILITY TO TRANSMIT ELECTRICAL IMPULSES


C. THE REGULATION OF NEUROTRANSMITTERS ESPECIALLY DOPAMINE


D. THE PERIPHERAL NERVOUS SYSTEM SENSITIVITY TO THE PSYCHOTROPIC MEDICATIONS




ANSWER: C
MEDICATIONS USED TO TREAT PSYCHIATRIC DISORDERS OPERATE IN AND AROUND THE
SYNAPTIC CLEFT AND HAVE ACTION AT THE NEUROTRANSMITTER LEVEL, ESPECIALLY IN THE
CASE OF SCHIZOPHRENIA, ON DOPAMINE. THE WERNICKES AREA, DENDRITE FUNCTION, OR
THE SENSITIVITY OF THE PERIPHERAL NERVOUS SYSTEM ARE NOT RELEVANT TO EITHER
SCHIZOPHRENIA OR PSYCHOTROPIC MEDICATIONS.
4. A STUDENT NURSE MUTTERS THAT IT SEEMS ENTIRELY UNNECESSARY TO HAVE TO
STRUGGLE WITH UNDERSTANDING THE ANATOMY AND PHYSIOLOGY OF THE NEUROLOGIC
SYSTEM. THE
MENTOR WOULD BASE A RESPONSE ON THE UNDERSTANDING THAT IT IS: NECESSARY
BUT GENERALLY FOR PSYCHIATRIC NURSES WHO FOCUS PRIMARILY ON


A.NECESSARY BUT GENERALLY FOR PSYCHIATRIC NURSES WHO FOCUS PRIMARILY ON
BEHAVIORAL INTERVENTION